Kathy Giusti, M.B.A. ’85, founder and CEO of the Multiple Myeloma Research Foundation (MMRF), will address this year's imminent graduates of Harvard Business School as Class Day speaker. She founded the MMRF in 1998 after being diagnosed with multiple myeloma. This spring, Time magazine named her one of the "100 most influential people" in the world. Multiple myeloma is a cancer of plasma cells—white blood cells that produce antibodies; it affects from one to four people per 100,000 and constitutes 1 percent of all cancers. Before starting MMRF, Giusti was an executive with pharmaceutical companies, and she has sought to encourage the development of drugs to treat the disease using a business model, rather than an academic model, of drug development. The MMRF is the world's top funder of myeloma research: it has raised more than $165 million to fund research.
Multiple myeloma research crusader Kathy Giusti to speak at HBS Class Day
Multiple myeloma research crusader Kathy Giusti to speak at HBS Class Day
The founder of the Multiple Myeloma Research Foundation will speak at Harvard Business School Class Day.
You might also like
Harvard Magazine Questionnaire: The True Cost of Grade Inflation
A faculty committee is recommending changes to grading at Harvard College to limit an overabundance of A's. Add your voice to the conversation.
Harvard Faculty Group Proposes Limits on A Grades
The grade inflation measure requires a full faculty vote, expected in the spring.
Harvard Students, Alumni to Compete at the 2026 Olympics
Six Crimson athletes are headed to the XXV Winter Games in Milano Cortina.
Most popular
Explore More From Current Issue
Getting to Mars (for Real)
Humans have been dreaming of living on the Red Planet for decades. Harvard researchers are on the case.
The Trouble with Sidechat
No one feels responsible for what happens on Harvard’s anonymous social media app.